Instil Bio Inc (TIL)
24.76
+1.40
(+5.99%)
USD |
NASDAQ |
Nov 21, 16:00
24.55
-0.21
(-0.85%)
After-Hours: 20:00
Instil Bio Price to Book Value: 0.9163 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.9163 |
| November 20, 2024 | 0.8645 |
| November 19, 2024 | 0.9696 |
| November 18, 2024 | 0.9204 |
| November 15, 2024 | 0.9807 |
| November 14, 2024 | 1.090 |
| November 13, 2024 | 1.167 |
| November 12, 2024 | 1.235 |
| November 11, 2024 | 1.245 |
| November 08, 2024 | 1.141 |
| November 07, 2024 | 1.052 |
| November 06, 2024 | 0.9177 |
| November 05, 2024 | 0.9792 |
| November 04, 2024 | 1.022 |
| November 01, 2024 | 1.065 |
| October 31, 2024 | 1.176 |
| October 30, 2024 | 1.269 |
| October 29, 2024 | 1.273 |
| October 28, 2024 | 1.306 |
| October 25, 2024 | 1.149 |
| October 24, 2024 | 1.143 |
| October 23, 2024 | 1.177 |
| October 22, 2024 | 1.243 |
| October 21, 2024 | 1.292 |
| October 18, 2024 | 1.386 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.460 |
| October 16, 2024 | 1.517 |
| October 15, 2024 | 1.491 |
| October 14, 2024 | 1.613 |
| October 11, 2024 | 1.557 |
| October 10, 2024 | 1.387 |
| October 09, 2024 | 1.431 |
| October 08, 2024 | 1.317 |
| October 07, 2024 | 1.478 |
| October 04, 2024 | 1.794 |
| October 03, 2024 | 1.935 |
| October 02, 2024 | 2.146 |
| October 01, 2024 | 2.267 |
| September 30, 2024 | 2.491 |
| September 27, 2024 | 2.188 |
| September 26, 2024 | 2.280 |
| September 25, 2024 | 2.304 |
| September 24, 2024 | 2.277 |
| September 23, 2024 | 2.251 |
| September 20, 2024 | 2.209 |
| September 19, 2024 | 1.959 |
| September 18, 2024 | 2.204 |
| September 17, 2024 | 2.161 |
| September 16, 2024 | 2.145 |
| September 13, 2024 | 2.819 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1518
Minimum
Dec 27 2022
4.854
Maximum
Mar 31 2021
1.492
Average
0.7742
Median
Nov 08 2022
Price to Book Value Benchmarks
| Merck & Co Inc | 5.676 |
| Elite Pharmaceuticals Inc | 13.96 |
| BioCardia Inc | 3.555 |
| Zevra Therapeutics Inc | 6.985 |
| NovaBay Pharmaceuticals Inc | 3.299 |
Price to Book Value Related Metrics
| Price | 24.76 |
| Earnings Yield | -46.69% |
| Market Cap | 161.58M |